High frequency of allele-specific rown-regulation of HLA class I expression in lung cancer cell lines

Akio Hiraki, Nobuharu Fujii, Tomoyuki Murakami, Katsuyuki Kiura, Keisuke Aoe, Hiromichi Yamane, Kozo Masuda, Tadashi Maeda, Kazuro Sugi, Zbigniew Darzynkiewicz, Mitsune Tanimoto, Mine Harada

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Loss or down-regulation of HLA expression has been demonstrated in various types of solid tumors and is considered to be one of the mechanisms of tumor immunoescape. The effectiveness of immunotherapy using tumor-specific antigens (TSA) largely depends on the expression of the appropriate HLA class I alleles on the tumor cells. We analyzed the allele-specific HLA class I surface expression of six lung cancer cell lines using a broad panel of allele-specific monoclonal antibodies, as well as the effect of IFN-γ on HLA expression. Flow cytometric analysis displayed a wide range, from minimal to a high degree of expression of monomorphic HLA class I among the studied cell lines. Allele-specific loss or down-regulation of HLA also was observed in 5 out of 6 cell lines. Our results suggest that lung cancer patients considered for specific immunotherapy should be examined with respect to the expression of specific HLA class I allele binding the TSA.

Original languageEnglish
Pages (from-to)1525-1528
Number of pages4
JournalAnticancer research
Volume24
Issue number3 A
Publication statusPublished - May 1 2004

Keywords

  • HLA
  • Immunoescape
  • Immunotherapy
  • Lung cancer cells

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'High frequency of allele-specific rown-regulation of HLA class I expression in lung cancer cell lines'. Together they form a unique fingerprint.

  • Cite this

    Hiraki, A., Fujii, N., Murakami, T., Kiura, K., Aoe, K., Yamane, H., Masuda, K., Maeda, T., Sugi, K., Darzynkiewicz, Z., Tanimoto, M., & Harada, M. (2004). High frequency of allele-specific rown-regulation of HLA class I expression in lung cancer cell lines. Anticancer research, 24(3 A), 1525-1528.